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Cobalt (III) tris(azido)-2-Morpholino-N-(1-(2-pyridyl)ethylidene)ethanamine complex  was synthesized, 
characterized and evaluated for in vitro anticancer activities. The chemical structure of the compound was 
assessed by elemental analysis, single crystal x-ray crystallography, FT-IR and UV-Visible spectroscopy. Schiff 
base molecule acts as tridentate ligand to form two five-membered chelate rings with the Co(III) ion. In the 
crystal structure three meridionally arranged nitrogen atoms from three azide ligands complete a distorted 
octahedral geometry around the metal center. The distortion from an ideal octahedron is evident from the cisoid 
[82.45(5)-96.03(5)⁰] and transoid [168.62(5)-177.62(5)⁰] angles. The azide groups are almost linear 
[175.65(15)-179.22(14)⁰] whereas the Co-N-N-N linkages are significantly bent [114.33(9)-123.13(9)⁰]. The 
novel cobalt(III) compound showed efficient anti-cancer activity against MCF-7 breast cancer cells. The 
compound was screened by MTT assay and was found to inhibit the growth of MCF-7 cells in a dose-dependent 
manner (IC50=2.80±0.02 µg/ml). The free ligand and free metal MTT assay showed no significant inhibition 
activities at a concentration even higher than the compound which confirmed that chelation of ligand with cobalt 
ion was significant for the activity of this novel compound. The cobalt compound activated caspase-3 via the 
intrinsic mitochondrial apoptotic pathway resulting in induces apoptosis on MCF-7 cell line.  
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1NTRODUCTION 
Transition metal complexes contribute 
largely to medicinal chemistry and are still the 
most widely used chemotherapeutic agents despite 
all limitations and side effects (Shazia et. al., 2010, 
Powis 1991). Their pharmacological activities are 
attributed to the nature of the metal or ligand or 
both.  
To design a metal complex for medical 
applications some important factors are considered 
such as maximum thermodynamic stability and 
large degree of selectivity. Metals from the first 
row transition play major roles in various 
biological activities and have been included in 
anticancer agents to exploit their various 
applications. This is because of the exceptionally 
wide range of reactivity available and have been 
particularly attractive (Petrovic 1996). They have 
been in use for medicinal purposes over a long 
period of time in a more or less empirical fashion 
(Thomson 2006), since the landmark discovery for 
the biological activity of cisplatin the potential of 
metal-based anticancer agents has been realized 
and explored (Shahabadi 2010). This has driven 
inorganic and organometallic chemists to look for 
new metal compounds with good activities, 
preferably against tumors that are responsible for 
high cancer mortality (El-sherif and Eldebss 2011). 
Therefore research has been extended to practically 
all metals, among which the Schiff base 
compounds of cobalt, copper, nickel, manganese, 
zinc, palladium, magnesium and gold and most 
transition metal compounds show most promising 
results (Bagihalli et. al., 2008, Creaven et. al., 
2010, Bernadette et. al., 2010, Garoufis et. al., 
2009, Wang et. al., 2005). Transition metal 
compounds offer a great diversity in their action. 
For example they have been reported to have anti-
cancer properties (Qiao et. al., 2011, Etcheverry et. 
al., 2012, Raman et. al., 2010, Shakir et. al., 2011), 
and have also been used as anti-inflammatory and 
anti-arthritic agents with DNA binding and DNA 
cleavage activities (El-sherif and Eldebss 2011). 
Morpholine derived compounds are 
completely stable in biological systems, allowing 
rigorous long-term applications as they constitute a 
radical re-design of DNA. When the 5-membered 
deoxyribose rings of DNA are replaced by 6-
membered morpholine rings; and the negatively 
charged inter-subunit linkages of DNA are replaced 
by non-ionic inter-subunit linkages (Summerton 
2007). These changes and consequence of their 
novel backbone structure provide decisive 
advantages over the more conventional oligo types 
used for modulating gene expression. 
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Cobalt is a key constituent of cobalamin 
and essential to all animals, including humans. 
Cobalamin which is also known as vitamin B12, is 
the primary biological reservoir of cobalt as an 
"ultratrace" element. It is widely distributed in the 
biological systems such as cells and body, and thus 
the interaction of DNA with cobalt compound has 
attracted much attention (Hisashi 2003). The 
binding properties of cobalt with calf thymus DNA 
were studied by several methods, and the 
experimental results showed that the size and shape 
of the intercalated ligand had an important effect on 
the binding affinity of the compounds with DNA 
(Vaidyanathan 2003). Hisaeda and co-workers 
(2003) discovered a new water-soluble dicobalt 
compound having two cobalt-carbon bonds and 
reported that this dicobalt compound showed 
higher ability for DNA cleavage in comparison 
with the corresponding monocobalt compound 
(Zhaang 2003). The interaction of DNA with 
cobalt(II) tridentate compound, and the 
photocleavage studies showed that the cobalt(II) 
compound increased to nicking of DNA in the 
presence of plasmid DNA (Jiao 2005). 
In this study, we examined the potential 
anti-cancer of cobalt(III) compound of N,N’,N” 
donor Schiff base ligand from the reaction of 4-(2-
aminoethyl)morpholine and 2-acetylpyridine in 
presence azide (N3- ion) for apoptotic application 
on human breast cancer MCF-7 cell line. 
 
MATERIALS AND METHODS 
Reagents and instrumentation 
All chemicals were of analytical grades 
and used without any further purification. 
Cobalt(II) acetate, sodium azide, 4-(2-
aminoethyl)morpholine and 2-acetylpyridine were 
purchased from  Aldrich–Sigma Company. Ethanol 
was distilled prior to use. Melting points were 
determined using an MEL-TEMP II melting point 
instrument. Microanalyses were carried out on a 
Perkin-Elmer 2400 elemental analyzer. 1H-NMR 
and 13C-NMR spectra were determined with a 
JEOL Lambda 400 MHz FT-NMR (1H: 400 MHz 
and 13C: 100.4 MHz) spectrometer. Chemical 
shifts are given in δ values (ppm) using TMS as the 
internal standard.  
Cell Lines 
Human breast cancer MCF-7 cell line was 
obtained from the American Type Culture 
Collection ATCC, USA. 
 
Synthesis of Cobalt(III)Complex  
A mixture of 2-acetylpyridine (0.20 g, 
1.65 mmol) and 4-(2-aminoethyl)morpholine (0.21 
g, 1.65 mmol) in ethanol (20 ml) was refluxed for 2 
hr followed by addition of a solution of cobalt(II) 
acetate tetrahydrate (0.41 g, 1.65 mmol) and 
sodium azide(0.22 g, 3.30 mmol) in a minimum 
amount of water. The resulting solution was 
refluxed for 30 mins, and then left at room 
temperature two days. The crystals of the title 
compound (Figure 1) were obtained in a two days; 
the resulting crystal was filtered off, washed with 
cold ethanol and dried over silica gel. Brown solid, 
95% yield, m.p. >400 ºC. Analytical calculated for 
C13H19CoN12O (418.3); Theory: C, 41.85; H, 5.67; 
N, 28.16. Found: C, 40.65; H, 5.60; N, 28.32. IR: 
ATR νmax/cm−1 3277.80 (CH aromatic), 2877.16, 
2944.00 (CH aliphatic), 1992.40 (N=N=N azide), 
1646.00 (C=N Schiff), 1428.41 (C-C), 1112.30 (C-
N), 571.87 (M-N). UV-Vis: λmax/nm DMSO 778.00 



















Fig. 1: Proposed synthesis scheme for [Co(N3)3(C13H19N3O)] 
 
Single Crystal X-Ray Diffraction 
Diffraction data were measured using a 
Bruker SMART Apex II CCD area-detector 
diffractometer (graphite-monochromated Mo K 
radiation, = 0.71073 Å). The orientation matrix, 
unit cell refinement and data reduction were all 
handled by the Apex2 software (SAINT 
integration, SADABS absorption correction) (Inc 
2007). The structure was solved using direct 
method in the program SHELXS-97 
(Sheldrickn20008) and was refined by the full 
matrix least-squares method on F2 with SHELXL-
97. All the non-hydrogen atoms were refined 
anisotropically and all the hydrogen atoms were 
placed at calculated positions and refined 
isotropically. Drawing of the molecule was 
produced with XSEED (Barbour 2001). Crystal 
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Table 1: Crystal data and refinement parameters of [Co(C13H19N3O)(N3)3]. 
Empirical formula   
Crystal system   
Space group   
Unit cell dimensions  
a (Å)                                                                              
b (Å)                                                                              
c (Å)                                                                                                                                                      
β (°)                                                                                                                                                           
Volume (Å3)  
Z  
Density (calculated) (g cm-3)  
Crystal size (mm3)  
θ range for data collection  (°)  
Reflections collected  
Independent reflections  
Completeness    
Data / restraints / parameters  
Goodness-of-fit on F2  
Final R indices [I>2σ (I)]  
R indices (all data)  











0.27 x 0.21 x 0.18 
2.03 to 27.00 
15495 
3783 [Rint = 0.0199] 
To θ = 27° :  99.9 %  
3783 / 2 / 245 
1.103 
R1 = 0.0223, wR2 = 0.0540 
R1 = 0.0253, wR2 = 0.0553 
 
Cytotoxicity evaluation 
MTT - Culture of cells and cytotoxicity assay 
Human breast cancer MCF-7 cell line was 
seeded into 96-well plate at an initial cell density of 
approximately 5x105 cells per well. After 24 hrs 
incubation for cell attachment and growth, the 
medium was removed and replaced with fresh 
medium containing different concentrations of the 
compounds. The compound added was first 
dissolved in DMSO at the 1.5, 3 and 4.5 µg/ml 
required concentrations. Subsequent six desirable 
concentrations were prepared using growth 
medium. Control wells received only DMSO. Each 
concentration of the compound was assayed in six 
replicates within 48 hrs incubation period. Again, 
the medium was removed and cell viability was 
determined after further 4 hrs with 5 mg per ml of 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium]bromide. DMSO was then 
added per well and the dissolving formazan 
precipitate was read by using elisa plate reader, 
Dynatech MR5000, at 570 nm and comparison was 
made with positive control tamoxifen.  
  
Determination of caspase-3 activity by 
absorption spectroscopy 
The measurement of caspase-3 activity 
was performed by caspase colormetric protease 
assay kit, according to manufacturer's instructions 
(Jun 2009). The absorbance of each sample at 405 
nm was read by a Bio-Rad 680 microplate reader. 
 
Statistical Analysis 
All data were expressed as Mean ± SD 
(standard deviation) by an assessment of 
differences using SPSS 16.0 software. 
 
 
Molecular Modeling Evaluations 
The coordinates for the enzyme were 
those deposited in the Protein Data Bank for 
caspase 3 (1PAU) after eliminating the inhibitor 
(AC-DEVD-CHO) and water molecules. The 
missing residues were built and polar hydrogen 
atoms were added using Discovery Studio 3.0 
(Accelrys, Inc., San Diego, CA, USA). By default, 
solvation parameters and Kollman charges were 
assigned to all atoms of the enzyme using 
AutoDock Tools v.1.4. The 3D structures of the 
compounds were optimized according to the 
standard protocol in Discovery Studio 3.0. For 
docking studies, the latest version of AutoDock 
v.4.0 (Morris 1998) was chosen because its 
algorithm allows full flexibility of small 
compounds. It has also been shown to successfully 
reproduce many crystal structure complexes and 
includes an empirical binding free energy 
evaluation. Docking of compounds to caspase 3 
was carried out using the hybrid Lamarckian 
Genetic Algorithm. A grid box with the size of 150 
x 140 x 110 grid box, and grid spacing of 0.375 Å 
was built to span the entire protein structure, in 
vacuo. The maximum number of energy 
evaluations was set to 25,000,000. Blind docking 
was used to predict structural features of compound 
binding. Resulting docked orientations within a 
root-mean square deviation of 1.5 Å were 
clustered. The lowest energy cluster reported by 
AutoDock for the compound was used for further 
analysis. All other parameters were maintained at 
their default settings. The structure of the complex 
obtained was visualized and analyzed using 
Discovery Studio Visualizer 3.0 and Ligplot 1.0 
(Wallace 1995) to identify specific interactions 
between the atoms of the compound and the 
enzyme. 




RESULTS AND DISCUSSION 
The N,N’,N” donor Schiff base was 
synthesized from the reaction of 4-(2-
aminoethyl)morpholine, with 2-acetylpyridine in 
presence of sodium azide N3- ion coordinates with 
cobalt(II) ion giving rise to coordination compound 
of cobalt(III). The characteristic IR stretching 
frequency of the metal compound along with the 
proposed assignments are summarized in 
experimental part. The IR spectra of all the 
compound possess very strong characteristic 
absorption bands in the region of 1649-1661cm-1 
which is attributed to the C=N stretching vibration 
of the Schiff base imino functional group, a similar 
has been reported. (Raman and Sudharsan 2011, 
Khan et. al., 2011, Nakamoto 1978, Laskar 2001). 
A chemical shift was observed at a region of 
2070cm-1 and 2043cm-1 which is attributed to 
cobalt to azide metal bond (Bhowmik et. al., 2010). 
The spectra for the compound showed M–N bands 
at a lower wavelength in the range of 477-575 cm-1 
(Salga 2012, Abdelaziz 2010). 
The electronic spectra for all the 
compounds were obtained in DMSO solvent and 
showed absorption band in three distinct regions. 
The first region ranging from 224 to approximately 
280 nm, is characteristic for the electronic inter-
ligand π→π* transitions (Mustapha 2009), while 
the second characteristic wavelength in the region 
of 281 nm to approximately 409 nm is the second 
inter ligand n→π transition (Yusnita 2009). The 
third distinct region ranging from 492 nm to 
approximately 606 nm is the characteristic for the 
ligand to metal charge transfer (LMCT) from the 
nitrogen atom to the transition metal centre 
(Yusnita 2009). The last distinct region ranging 
from 650 nm to approximately 750 nm is the 
characteristic for the inter metal d→ d* transition 
(Yusnita 2009). 
The molecular structure of Co(III) 
compound is depicted in (Figure 2) and selected 
bond lengths and angles are listed in Table 2. In the 
compound, the Schiff base molecule acts as an 
N,N’,N”-tridentate ligand to form two five-
membered chelate rings with the Co(III) atom. 
Three meridionally arranged nitrogen atoms from 
three azide ligands complete a distorted octahedral 
geometry around the metal center. The distortion 
from an ideal octahedron is evident from the cisoid 
[82.45(5)-96.03(5)⁰] and transoid [168.62(5)-
177.62(5)⁰] angles (Table 2). The azide groups are 
almost linear [175.65(15)-179.22(14)⁰] whereas the 
Co-N-N-N linkages are significantly bent 
[114.33(9)-123.13(9)⁰]. The Co-N bond lengths are 




Fig. 2: The molecular structure of [Co(N3)3(C13H19N3O)] (30% probability ellipsoids). Hydrogen atoms are 





Table 2: Selected bond lengths [Å] and bond angles [°] of [Co(C13H19N3O)(N3)3]. 





Co(1)-N(2)                  1.8777(11) 
Co(1)-N(1)                  1.9257(11) 
Co(1)-N(4)                  1.9407(11) 
Co(1)-N(10)                  1.9699(12) 
Co(1)-N(7)                  1.9777(12) 
Co(1)-N(3)                  2.0334(11) 
Bond angles 
N(2)-Co(1)-N(1)   82.45(5) 
N(2)-Co(1)-N(4)   175.54(5) 
N(1)-Co(1)-N(4)   96.03(5) 
N(2)-Co(1)-N(10)   88.04(5) 
N(1)-Co(1)-N(10)   89.02(5) 
N(4)-Co(1)-N(10)   87.74(5) 
N(2)-Co(1)-N(7)   92.68(5) 
N(1)-Co(1)-N(7)   88.83(5) 
N(4)-Co(1)-N(7)   91.48(5) 
N(10)-Co(1)-N(7)            177.62(5) 









N(4)-N(5)           1.2018(16) 
N(5)-N(6)                   1.1514(17) 
N(7)-N(8)           1.2104(16) 
N(8)-N(9)           1.1545(17) 
N(10)-N(11)           1.2079(16) 
N(11)-N(12)           1.1552(17) 
 
N(1)-Co(1)-N(3)         168.62(5) 
N(4)-Co(1)-N(3)         95.18(5) 
N(10)-Co(1)-N(3)       93.39(5) 
N(7)-Co(1)-N(3)         88.92(5) 
N(6)-N(5)-N(4)          175.65(15) 
N(9)-N(8)-N(7)          179.22(14) 
N(12)-N(11)-N(10)    177.56(14) 
N(5)-N(4)-Co(1)        123.13(9) 
N(8)-N(7)-Co(1)        114.85(9) 
N(11)-N(10)-Co(1)     114.33(9) 
  
 
The Co(II) ion with its d7 configuration 
commonly exhibits octahedral geometries 
(Bagihalli 2008).  The d-d peaks on the spectrum 
(Figure 3) are transitions for the d6 cobalt(III) 
complex in [Co(LMA)(N3)3] bands at 240, 395, 
416, 596 nm attributable to 1A1g→3A1g; 
1Aig→3T2g and 1Aig→5T2g Judging by the 
Tanabe-Sugano diagram for d6 complexes, the 
ground state 5D would be split into a 5T2g and a 
5Eg. The stronger of the two peaks is most likely 
the transition between these two states. The weaker 
peak may be a spin-forbidden transition, which 
cannot be accurately predicted. The complex is 
most likely weak field, with four unpaired 
electrons.  
 
Fig. 3: Electronic spectra for [Co(N3)3(C13H19N3O)] 
MTT assay was used to determine the 
cobalt compound cytotoxicity against human breast 
cancer MCF-7cell line. This assay served as an 
index used to determine cytotoxicity of cobalt 
compound to stimulate or inhibit cell viability and 
growth. This is by detecting the reduction of 
tetrazolium salt to blue formazan by mitochondrial 
enzyme activity of succinate dehydrogenase in 
living cells. MCF-7 cells were treated with 
different concentrations of the cobalt compound for 
48 h, and the cells viability were measured by MTT 
assay. The cobalt(III) compound was found to 
inhibit the growth of MCF-7 cells in a dose-
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MTT assay of free ligand and free metal showed no 
significant inhibition activities at a concentration 
even higher than the chelation of ligand with cobalt 
ion was observed (Table 3).  
Clonogenic assay is used for studying the 
effectiveness of specific agents on the survival and 
proliferation of cells. In this study the effectiveness 
for the cytotoxicity of cobalt(III) compound to 
inhibit growth of MCF-7 cells was determined; 
Cells were trypsinised and counted to a ratio of 5 × 
103 cells per plate. The colony-forming cells 
number using the cobalt compound at 
concentration of 2.80, 3.72 and 4.53 µg/ml was 
reduced compared to the untreated MCF-7 as a 
control. No colony observed at the concentration of 
higher than 8.56 µg/ml, indicating the cobalt(III) 
compound showed toxicity and inhibited the 
proliferation of MCF-7 cell. Toxicity of compound 
was further supported by clonogenic efficiency 
(CE) which is the number of colonies divided by 
the number of cells added to each plate. This result 




Table 3 Comparison of clonogenic efficiency (CE) at different concentrations with untreated cell line 







*CE: Clonogenic efficiency. 
 
To further confirmation of the cobalt compound 
induced apoptosis in MCF-7 cells, caspase activity 
and potential molecular mechanisms involved were 
measured, colorimetric was upon treatment with 
1.5, 3 and 4.5 µg/ml cobalt compound for 48 h. The 
activity of caspase-3 increased remarkably in 
MCF-7 cells after administration of cobalt 
compound via the intrinsic mitochondrial apoptotic 
pathway in caspase-3 activity, which confirmed the 
apoptosis of MCF-7 cells induced by cobalt 
compound (Figure 4).  
 
 Different concentrations 
of compound (µg/ml) 
 Apoptotic colonies  














100 No colony 
0 
Co(III) 12.45±0.03 










Fig. 4: The activities of caspase-3 after treatment with various concentrations of [Co(N3)3(C13H19N3O)] 
compound for 48 h. The activities of caspase-3 were expressed relative to the untreated control. The results are 
expressed as the Mean ± SD (n=3) 
 
Caspase 3 (pdb id: 1PAU) is a member of the 
cysteine-aspartic acid protease (caspase) family 
(Alnemri 1996). Sequential activation of caspase 3 
plays a central role in the execution-phase of cell 
apoptosis. The catalytic site of caspase-3 involves 
the sulfohydryl group of Cys-285 and the imidazole 
ring of His-237. His-237 stabilizes the carbonyl 
group of the key aspartate residue, while Cys-285 
attacks to ultimately cleave the peptide bond. Cys-
285 and Gly-238 also function to stabilize the 
tetrahedral transition state of the substrate-enzyme 
complex through hydrogen bonding (Lavrik 2005). 
 






















Fig. 5(a) Representations of the molecular model of the complex formed between [Co(N3)3(C13H19N3O)] and 
Caspase 3 (1PAU). (b) 3D representation of the ligand-enzyme binding interactions, cobalt(III) is represented as 
a dark grey sticks and hydrogen bonds as green dashed lines; (c) 2D schematic representation of the hydrogen 
bonding and hydrophobic interactions. 
From the molecular docking simulation 
carried out, it can be seen that the residues involved 
in the interactions with the cobalt(III) compound 
are Asn 342, Asp 345, Asp 502, Gln 351, Glu 379, 
Glu 380, Glu 381, Phe 380, Phe 381, Ser 381, and 
Trp 348 (Figure 5 a-c). The complex formed between 
cobalt(III) compound and caspase 3 showed that the 
ligand does not bind to the active-site gorge. and 
due to the fact that the caspase-3 zymogen has 
virtually no activity until it is cleaved by an 
initiator caspase after apoptotic signaling events 
have occurred (WALTERS 2009) therefore, the 
introduction of cobalt(III) compound can activate 
caspase 3 initiator, into cells targeted for apoptosis 
(Gallaher 2001, Katunuma 2001). This extrinsic 
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activation then triggers the hallmark caspase 
cascade characteristic of the apoptotic pathway, in 
which caspase-3 plays a dominant role (Perry 
1997). In intrinsic activation, cytochrome c from 
the mitochondria works in combination with ATP 
to process procaspase-3 (Katunuma 2001, Porter 
1999, Li 2004). This is evident that this compound 
activated caspase-3 in vitro, but other regulatory 
proteins are necessary in vivo (Li 2004). 
A closer inspection of the interactions 
(Fig. 5b) showed the presence of hydrogen bond 
between the oxygen attached to the morpholine 
group with Gln 351 (B), π-π and cation-π stacking 
involving between nitrogen atoms from the azide 
groups and Glu 379(A), Glu 381(B) and Asp 
502(C). Furthermore, hydrophobic interactions 
between ligand and caspase 3 residues [Phe 381 
B(B), Asp 345 (B), Phe380 (B), Trp 348 (B) and 
Asn 342(B)] was observed which enables the 
morpholine oxygen to form a hydrogen bond with 
Gln 351(B) and  azide groups to form a cluster of 
networking hydrogen bonds with Asp 502(C) and 
Glu 381(B). 
The studies of Reactive oxygen species 
ROS effects on biological systems, underlying 
mechanisms and therapeutic implications largely 
depend on proper experimental models (Weiqin 
2007). Figure 8 shows the ROS values for the 
[Co(N3)3(C13H19N3O)] compound in two different 
concentrations (1.5ug/ml = 704 and 2ug/ml = 
793.5) higher than the control (Figure 6). Increased 
generation of reactive oxygen species (ROS) has 
been observed in cancer, degenerative diseases, and 
other pathological conditions (Weiqin 2007). 
Evidence exists that the role of ROS in cancer is 
not limited to the generally accepted genotoxicity 
and mutagenic effects that initiate cancer. As signal 
transduction messengers, ROS may promote either 
proliferation or death of cancer cells, depending on 
the actual intracellular and exogenous conditions 
(Gina et. al., 2009). ROS were shown to modulate 
growth signals and to activate gene expression, 
leading to sustained proliferation of cancer cells 




Fig. 6: ROS values for the [Co(N3)3(C13H19N3O)] compound in two different concentrations 
 
CONCLUSIONS 
In this study, we have studied interaction 
of [Co(N3)3(C13H19N3O)] Schiff base compound 
with nucleic acids and analyzed its biochemical 
effect on human breast cell line. X-ray crystal 
structures of this compound exhibits 
[Co(N3)3(C13H19N3O)] in a distorted octahedral 
geometry around the metal center with the Schiff 
base ligand having an N, N, N chelating motif. In 
cytotoxicity research, the compound showed high 
in vitro cytotoxic properties with significant growth 
inhibition activity against MCF-7cell line. The 
compound could induce apoptosis by alteration of 
nucleus morphology and mitochondrial membrane 
changes, inhibition of colony formation, DNA 
fragmentation and cytopathologic effects on the 
MCF-7 cells. The potential mechanism for 
apoptosis induction was attributed to triggering the 
intrinsic mitochondrial apoptotic pathway owing to 
activation of caspase-3. The data from our present 
study suggested that the efficient capability of the 
compound to inhibit growth activities as anti-
cancer compound against human breast MCF-7cell 
line in which deserves further investigation on 
other human cell lines as new antitumor drug. 
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